|
After
completing undergraduate work in Chemistry at Rutgers University,
Charles Thompson received M.S. (1980) and Ph.D. (1982) degrees in
Chemistry from The University of California, Riverside. Following
postdoctoral appointments at Harvard University (1982-1983) and The
University of California, Berkeley (1983-1985) he held a faculty
position in Chemistry at Loyola University of Chicago (1985-1994).
He moved to the University of Montana as an Associate Professor
in 1994 and was promoted to Professor in 1996. In 2000, he became
the co-Director of the University of Montana National Science Foundation
(NSF) Experimental program to Stimulate Competitive Research (EPSCoR)
at the University of Montana.
_______________________________________________________________
INTERESTS OF THE THOMPSON LABORATORY
Research
in our group uses a combination of [bio]chemical, cellular and spectroscopic
approaches to solve problems in neuroscience, particularly the neurotransmitter
systems, glutamate acetylcholine and glutamate. Four principal approaches
a currently underway include:
1)
Design and synthesis of pharmacologically active compounds to
probe, regulate and inhibit neurotransmitter systems.
2) Computer-aided modeling to design, simulate and visualize pharmacophore
models for receptors, enzymes and transporters.
3) Application of proteomics to neurotransmitter systems.
4) Development and applications of custom-tailored antibodies
for immunologic detection in neurotransmitter systems.
Glutamate
Neurotransmitter System: The primary goal of this project is to
define the structural requirements for selective and potent binding
to the vesicular glutamate transporter (VGLUT) protein. The long-range
goal of this study is to develop a pharmacophore model of the glutamate
vesicular transporter protein and utilize this information to regulate
vesicular storage, uptake and release of glutamate. To date, few
competitive inhibitors have been identified and therefore the principle
strategy of our work is to design and synthesize new inhibitors
using the structural and functional group characteristics of certain
known inhibitors in combination with key features of the glutamate
molecule. Once identified, the new inhibitor library will be used
to develop a pharmacophore model and affinity ligands to probe the
structure and function of the transporter.
Acetylcholine
Neurotransmitter System: Our principle aim is to study how organophosphate
(OP) insecticides may be partially or wholly responsible for an
diverse array of modes of toxic action. Most OP insecticides (e.g.,
malathion, diazinon, chlorpyriphos, etc.) impart their toxic action
by initial conversion to an oxon which then inhibits acetylcholinesterase
(the enzyme responsible for the hydrolysis of the neurotransmitter
acetylcholine). Following cholinesterase inhibition, the organism
generally dies of complications associated with cholinergic poisoning.
However, more recent evidence suggests that OP compounds may injure
cells and/or covalently modify non-target proteins via non-cholinergic
modes of action. Using neuronal cell culture and AChE knock-outs,
our goal is to identify non-target proteins that are susceptible
to OP's and to identify proteins that are up- or down-regulated
in response to an OP insult
Some of the specific questions we are trying to answer in the glutamate
and acetylcholine neurotransmitter system include:
1)
What is the consequence of neurotransmitter system proteins that
have been irreversibly modified by chemical agents?
2) Can structural and functional group analogues of glutamate
and acetylcholine be used to probe the structure and function
of proteins that regulate the binding and translocation of neurotransmitters?
3) Do organophosphate insecticides and their impurities react
with non-target proteins and do these reactions lead to deleterious
health effects of the nervous system?
_______________________________________________________________
SELECTED PUBLICATIONS
Thiagaraj,
H.V.; Russo, E.B.; Burnett, A.; Goldstein, E.; Thompson, C.M.;
Parker, K.K. (2005) Binding Properties of Dipropyltryptamine at
the Human 5HT1a Receptor. Pharmacology (in press).
Lockridge,
O., Duysen, E. G.; Voelker, T.; Thompson, C.M.; Schopfer, L.M. (2005)
Life Without Acetylcholinesterase: The Implications of Cholinesterase
Inhibitor Toxicity in AChE-Knockout Mice." Environ. Tox.
Pharmacol (in press).
Peeples,
E.; Schopfer, L.M.; Duysen, E.G.; Spaulding, R.; Voelker, T.; Thompson,
C.M.; Lockridge, O. (2005) Albumin, a New Biomarker of OP Exposure
Identified by Mass Spectroscopy. Toxicological Sci. 83: 303-312.
Tongcharoensirikul,
P.; Suarez, A.I.; Voelker, T. Thompson, C.M. (2004) Effect of Chiral
Auxiliaries on the Stereoselective Addition of Dimethyl Thiophosphite
to Imines. J. Org. Chem. 69: 2322-2326.
Thompson,
C. M., Richardson, R. J. (2004) Anticholinesterase Insecticides.
In Pesticide Toxicology and International Regulation (Current Toxicology
Series), Marrs, T. C. and Ballantyne, B., Eds. John Wiley &
Sons Ltd, Chichester,
(2004) 89-127.
Coughenour,
H.D.; Spaulding, R.S.; Thompson, C.M. (2004) The Synaptic Vesicle
Proteome: A Comparative Study in Membrane Protein Identification.
Proteomics, 4: 3141-3155.
|